To determine if the expansion of T cells in the DCIS lesions was affecting the growth of the tumor cells, we analyzed the expression of a proliferation marker (Ki67) and a marker of apoptosis (cleaved caspase 3; CC3). This evidence concerns the gene CASP3 and ductal breast carcinoma in situ.